Background: Over the last 15 years, many studies demonstrated the myogenic regenerative potential of bone marrow mesenchymal stem cells (BM-MSC), making them an attractive tool for the regeneration of damaged tissues. In this study, we have developed an animal model of esophagogastric myotomy (MY) aimed at determining the role of autologous MSC in the regeneration of the lower esophageal sphincter (LES) after surgery. Methods: Syngeneic BM-MSC were locally injected at the site of MY. Histological and functional analysis were performed to evaluate muscle regeneration, contractive capacity, and the presence of green fluorescent protein-positive BM-MSC (BM-MSC-GFP+) in the damaged area at different time points from implantation. Key Results: Treatment with syngeneic BM-MSC improved muscle regeneration and increased contractile function of damaged LES. Transplanted BM-MSC-GFP+ remained on site up to 30 days post injection. Immunohistochemical analysis demonstrated that MSC maintain their phenotype and no differentiation toward smooth or striated muscle was shown at any time point. Conclusions & Inferences: Our data support the use of autologous BM-MSC to both improve sphincter regeneration of LES and to control the gastro-esophageal reflux after MY. © 2013 John Wiley & Sons Ltd.

Mazzanti, B., Lorenzi, B., Lorenzoni, P., Borghini, A., Boieri, M., Lorenzi, M., et al. (2013). Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. NEUROGASTROENTEROLOGY AND MOTILITY, 25(10), 669-679 [10.1111/nmo.12182].

Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model

Lorenzi, B.;Lorenzoni, Paola;Borghini, A.;Lorenzi, Marco;Weber, Elisabetta;Pessina, Federica
2013-01-01

Abstract

Background: Over the last 15 years, many studies demonstrated the myogenic regenerative potential of bone marrow mesenchymal stem cells (BM-MSC), making them an attractive tool for the regeneration of damaged tissues. In this study, we have developed an animal model of esophagogastric myotomy (MY) aimed at determining the role of autologous MSC in the regeneration of the lower esophageal sphincter (LES) after surgery. Methods: Syngeneic BM-MSC were locally injected at the site of MY. Histological and functional analysis were performed to evaluate muscle regeneration, contractive capacity, and the presence of green fluorescent protein-positive BM-MSC (BM-MSC-GFP+) in the damaged area at different time points from implantation. Key Results: Treatment with syngeneic BM-MSC improved muscle regeneration and increased contractile function of damaged LES. Transplanted BM-MSC-GFP+ remained on site up to 30 days post injection. Immunohistochemical analysis demonstrated that MSC maintain their phenotype and no differentiation toward smooth or striated muscle was shown at any time point. Conclusions & Inferences: Our data support the use of autologous BM-MSC to both improve sphincter regeneration of LES and to control the gastro-esophageal reflux after MY. © 2013 John Wiley & Sons Ltd.
2013
Mazzanti, B., Lorenzi, B., Lorenzoni, P., Borghini, A., Boieri, M., Lorenzi, M., et al. (2013). Treatment of experimental esophagogastric myotomy with bone marrow mesenchymal stem cells in a rat model. NEUROGASTROENTEROLOGY AND MOTILITY, 25(10), 669-679 [10.1111/nmo.12182].
File in questo prodotto:
File Dimensione Formato  
paper13.pdf

non disponibili

Tipologia: Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.1 MB
Formato Adobe PDF
1.1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/45019
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo